CRISPR Therapeutics AG Receivables for the year ending December 31, 2024: USD 25.00 M

CRISPR Therapeutics AG Receivables is USD 25.00 M for the year ending December 31, 2024, a -87.50% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • CRISPR Therapeutics AG Receivables for the year ending December 31, 2023 was USD 200.00 M.
  • CRISPR Therapeutics AG Receivables for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
  • CRISPR Therapeutics AG Receivables for the year ending December 31, 2021 was USD 305.00 K, a 111.81% change year over year.
  • CRISPR Therapeutics AG Receivables for the year ending December 31, 2020 was USD 144.00 K, a 45.45% change year over year.
Key Data
Date Receivables Inventory Current Assets Property, Plant, Equipment (Net)